The first chairman of the Subcommittee, Dr. Shields Warren, resigned in 1951, to be succeeded by Dr. Lucké who, as chairman, performed the last of his many services to the Institute until his death in 1954, when Dr. Arthur
Purdy Stout of the Institute of Cancer Research of Columbia University became chairman. Dr. Paul Steiner of the University of Pennsylvania and Dr. Lauren Ackerman of Washington University, a member of the International Committee on Oncological Nomenclature, were added to the membership of the committee before the move into the new building.
Acceptance of the Atlas has been worldwide, with from 12 to 25 percent of the distribution in foreign lands. The fascicles have met with hearty acclaim abroad as well as at home, although there was some feeling abroad that "perhaps not enough attention has been paid to the nomenclature and opinions of non-American pathologists," as Dr. Stout put it in an editorial article in the American Journal of Clinical Pathology. 14[1]
The degree of acceptance of the Atlas by the medical profession is indicated by the growing demand for the fascicles as they have appeared. The original print orders were for 5,000 copies of each, a figure which has been increased to 7,500 copies, then to 10,000, and now to 15,000 copies.
In 1949, the year in which the first fascicles appeared, the American Registry of Pathology was designated as the department of the Institute through which sales of the fascicles would be handled. Four years later, in October 1953, Dr. Hugh G. Grady (fig. 102), who had succeeded Col. James E. Ash as Scientific Director of the Registry in 1949, reported that the first four fascicles had been "completely sold out." This "tremendous sale," he added, has been done with nothing resembling a sales organization or any worth- while advertising." 15[2] In 1954, the last year in the old building, 17,623 copies of fascicles were sold, still without a sales organization in the usual sense, and still without advertising other than word-of-mouth reporting of the merits of the publications. 16[3]
The fascicles which were sold out have been reprinted, whenever it has been possible to do so without holding up the printing of those as yet unissued, and others which are now out of print will doubtless be reproduced as opportunity offers.
Another arm of the Institute which has a part in the enterprise of publishing the "Atlas of Tumor Pathology" is the Medical Illustration Service, which
